Detalhe da pesquisa
1.
Systematic Assessment of Antiviral Potency, Breadth, and Synergy of Triple Broadly Neutralizing Antibody Combinations against Simian-Human Immunodeficiency Viruses.
J Virol;
95(3)2021 01 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33177194
2.
Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus Challenge.
J Virol;
93(20)2019 10 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31341049
3.
Clade C HIV-1 Envelope Vaccination Regimens Differ in Their Ability To Elicit Antibodies with Moderate Neutralization Breadth against Genetically Diverse Tier 2 HIV-1 Envelope Variants.
J Virol;
93(7)2019 04 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30651354
4.
High Doses of GM-CSF Inhibit Antibody Responses in Rectal Secretions and Diminish Modified Vaccinia Ankara/Simian Immunodeficiency Virus Vaccine Protection in TRIM5α-Restrictive Macaques.
J Immunol;
197(9): 3586-3596, 2016 11 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27683750
5.
Intradermal but not intramuscular modified vaccinia Ankara immunizations protect against intravaginal tier2 simian-human immunodeficiency virus challenges in female macaques.
Nat Commun;
14(1): 4789, 2023 08 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37553348
6.
V2 hotspot optimized MVA vaccine expressing stabilized HIV-1 Clade C envelope Gp140 delays acquisition of heterologous Clade C Tier 2 challenges in Mamu-A*01 negative Rhesus Macaques.
Front Immunol;
13: 914969, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35935987
7.
Challenges and Opportunities of Therapies Targeting Early Life Immunity for Pediatric HIV Cure.
Front Immunol;
13: 885272, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35911681
8.
Structure-guided changes at the V2 apex of HIV-1 clade C trimer enhance elicitation of autologous neutralizing and broad V1V2-scaffold antibodies.
Cell Rep;
38(9): 110436, 2022 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35235790
9.
Lymph node CXCR5+ NK cells associate with control of chronic SHIV infection.
JCI Insight;
7(8)2022 04 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35271506
10.
A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaques.
Sci Immunol;
7(73): eabl4102, 2022 07 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35867800
11.
SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung.
Nat Commun;
12(1): 3587, 2021 06 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34117252
12.
T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers.
Nat Med;
26(6): 932-940, 2020 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32393800
13.
Functional MAIT Cells Are Associated With Reduced Simian-Human Immunodeficiency Virus Infection.
Front Immunol;
10: 3053, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32010135
14.
Correlates of Protection Against SIVmac251 Infection in Rhesus Macaques Immunized With Chimpanzee-Derived Adenovirus Vectors.
EBioMedicine;
31: 25-35, 2018 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29685793